Results 181 to 190 of about 196,489 (314)

Cross‐continental transmission and host adaptation of Mycobacterium tuberculosis in China unveiled by population history reconstruction and adaptive evolution signal detection

open access: yesiMetaOmics, EarlyView.
This study showed that four Mycobacterium tuberculosis complex (MTBC) sub‐lineages might be introduced into China 1000–400 years ago via Europe‐China dispersal routes, where they diversified into local clades, and later underwent population expansions that coincided with periods of climatic cooling and warfare.
Wei Wu   +16 more
wiley   +1 more source

citrOgen: a synthesis-free polysaccharide and protein antigen-presentation to antibody-induction platform. [PDF]

open access: yesNat Commun
Wong JLC   +5 more
europepmc   +1 more source

Heterologous antilymphocyte globulin, histoincompatibility matching and human renal homotransplantation

open access: bronze, 1969
TE Starzl   +5 more
openalex   +1 more source

Tumor cell‐derived vaccines: Advances, challenges, and future prospects

open access: yesInterdisciplinary Medicine, EarlyView.
Classification and Optimization Directions for Tumor Cell‐Derived Vaccines. This diagram systematically illustrates the four major categories of tumor cell‐derived vaccines, along with their core optimization strategies. The upper section presents the four primary vaccine types: autologous/allogeneic whole‐cell vaccines (which preserve the complete ...
Jiaye Lu   +9 more
wiley   +1 more source

Heterologous biosynthesis of cotylenol and concise synthesis of fusicoccane diterpenoids. [PDF]

open access: yesBeilstein J Org Chem
Yuan Y   +7 more
europepmc   +1 more source

Survival of Heterologous Mammalian Transplants

open access: green, 1962
Harvey B. Stone, William J. Kennedy
openalex   +2 more sources

Evaluation of the Pharmacokinetics, Disposition, and Metabolism of Miricorilant, a Novel Glucocorticoid Receptor Modulator for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis in Nonclinical and Clinical Studies

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Miricorilant is a novel selective glucocorticoid receptor (GR) modulator with mixed agonist/antagonist effects at the GR and modest antagonism at the mineralocorticoid receptor that is being developed for the treatment of metabolic dysfunction‐associated steatohepatitis.
Hazel J. Hunt   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy